Searched for
NPPA HOSPITAL PRICING
Rs 11 IV for Rs 325, Rs 6 syringe for Rs 57: Tukaram Mundhe flags 2,841% inflated hospital bills that patients don't even know, sends recommendation to CentreMaharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
- Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposalThe National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...
- Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...
- Hospitals may face more pricing restrictions: IcraThe hospitals sector has been under the regulatory scanner lately with the NPPA announcing price caps on stents last February and on knee i...
- 4 NCR hospitals jacked up prices of branded drugs 12 fold: NPPAThe hospitals have been the “major beneficiaries” of profit in all these cases because they inflated the maximum retail prices of the produ...
- Hospitals prescribe drugs excluded from price control to boost profit: NPPAFour hospitals in the NCR marked up the retail prices of such medicines as much as 12-fold from the rates at which they were purchased, NPP...
- Private hospitals making up to 1,737% profit on drugs, finds NPPA studyNPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than dru...
- NPPA threatens legal action against 40 hospitals for not displaying knee implant pricesThe drug pricing watchdog has threatened action against these hospitals, which were expected to make the revised prices available online so...
- Trade margins on knee implants as much as 300%, says regulatorA total knee system can cost a patient as much as Rs 4.13 lakh and a minimum of Rs 59,091, while import prices ranged between Rs 23,408 and...
- NPPA moves to prevent distributors from taking higher cuts on stentsThrough this move, NPPA has plugged the gap for ‘manipulating’ trade margins in coronary stents, the regulator’s chairman stated on Twitter.
- NPPA to penalise companies offering freebies on stent salesInstances have come to the notice of NPPA that few companies dealing with coronary stents have come up with freebies by announcing schemes.
- NPPA asks hospitals, doctors to report stents shortageThe regulator has been taking several steps to ensure stents are available under its prescribed price list as reports emerged that there we...
- Stents pricing: Govt asks hospitals to make prompt refundsThe National Pharmaceutical Pricing Authority (NPPA) said the matter would end there for such hospitals if there were no further complaints.
- NPPA sends show cause notices to hospitals over stent overpricing allegationsThese show cause notices have been sent after preliminary investigations into these allegations, the regulator disclosed on its official ac...
- Max Healthcare, Lilavati deny overcharging on stentsWe have not overcharged even a single patient for stent. We have complied fully and immediately with the NPPA order on stent pricing, a Max...
- Top hospitals under regulator’s lens for overcharging patients for stentsThe department of pharmaceutical has also invoked special provisions under the DPCO to ensure compliance with the pricing order as well as ...
- Hospitals can't refuse to sell patients the stents they demand: NPPAIn case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...
- NPPA warns stent makers, importers against shortageLast week, the government had slashed prices of stents by up to 85 per cent by capping them at Rs 7,260 for bare metal ones and Rs 29,600 f...
- NPPA slashes margins on stents for hospitals, distributorsNow, patients purchasing stents at their maximum price won’t pay hospitals margins of more than Rs 2,400 on DES and BVS and about Rs 581 on...
Load More
